Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.24854
Abstract: A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor‐ivacaftor, tezacaftor‐ivacaftor, and elexacaftor‐tezacaftor‐ivacaftor. This cross‐sectional study evaluated cystic fibrosis (CF) patients eligible for… read more here.
Keywords: cystic fibrosis; eligible modulator; patients eligible; modulator drugs ... See more keywords